Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ASP Isotopes Inc.ASPI · Entity 5371 | Director · 10% owner | November 15, 2022 | November 16, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ASP Isotopes Inc.
Report date November 15, 2022 · Filed November 16, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 3,797,423 |
Reported balance
After 2022-11-15 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2022-11-15 · Grant · Acquired 200,000 · Balance 3,797,423 F1: The special one-time award of 200,000 restricted shares were contingent upon the completion of our IPO. Dr. Strydom will receive 100,000 restricted shares of our common stock on November 15, 2023 and 100,000 restricted shares of our common stock on November 15, 2024. F2: Dr. Strydom beneficially owns 3,797,423 shares indirectly through Tianne Holdings (Pty) Ltd. |
Filing footnotes · ownership attribution and instrument terms
F1: The special one-time award of 200,000 restricted shares were contingent upon the completion of our IPO. Dr. Strydom will receive 100,000 restricted shares of our common stock on November 15, 2023 and 100,000 restricted shares of our common stock on November 15, 2024.
F2: Dr. Strydom beneficially owns 3,797,423 shares indirectly through Tianne Holdings (Pty) Ltd.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 15, 2022 Filed Nov 16, 2022 17:44 UTC | ASP Isotopes Inc. ASPI · Entity 5371 | GrantCommon Stock | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-073095 · ownership.xml · nonDerivative · entry 1 Strydom Hendrik · CIK 0001951278 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 3,797,423 F1 · deemedExecutionDate: The special one-time award of 200,000 restricted shares were contingent upon the completion of our IPO. Dr. Strydom will receive 100,000 restricted shares of our common stock on November 15, 2023 and 100,000 restricted shares of our common stock on November 15, 2024. F2 · ownership.nature: Dr. Strydom beneficially owns 3,797,423 shares indirectly through Tianne Holdings (Pty) Ltd. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.